These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 14560865)

  • 1. Liver transplantation for hepatocellular carcinoma: how far can we push the envelope?
    Tan KC
    Singapore Med J; 2003 Jun; 44(6):309-11. PubMed ID: 14560865
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome.
    Arikan C; Kilic M; Nart D; Ozgenc F; Ozkan T; Tokat Y; Yagci RV; Aydogdu S
    Pediatr Transplant; 2006 Feb; 10(1):42-7. PubMed ID: 16499586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation: the preferred treatment for early hepatocellular carcinoma in the setting of cirrhosis?
    Schwartz M
    Ann Surg Oncol; 2007 Feb; 14(2):548-52. PubMed ID: 17009143
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances and controversies in liver transplantation: hepatocellular cancer, viral hepatitis, and living donor liver transplantation in adults. AASLD/ILTS liver transplantation course. October 27, 2000.
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S1-80. PubMed ID: 11142912
    [No Abstract]   [Full Text] [Related]  

  • 5. Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?--no, never.
    Hiatt JR; Carmody IC; Busuttil RW
    J Hepatol; 2005 Oct; 43(4):573-7. PubMed ID: 16112768
    [No Abstract]   [Full Text] [Related]  

  • 6. [Living donor liver transplantation for the patient with hepatocellular carcinoma].
    Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Maehara Y
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2118-21. PubMed ID: 15628755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver.
    Chang CH; Chau GY; Lui WY; Tsay SH; King KL; Wu CW
    Arch Surg; 2004 Mar; 139(3):320-5; discussion 326. PubMed ID: 15006892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent hepatocellular carcinoma after living donor liver transplantation: a preventable problem or an acceptable risk?
    Sonnenday CJ
    Ann Surg Oncol; 2010 Sep; 17(9):2262-3. PubMed ID: 20431956
    [No Abstract]   [Full Text] [Related]  

  • 9. Should we expand the criteria for liver transplantation for hepatocellular carcinoma--yes, of course!
    Broelsch CE; Frilling A; Malago M
    J Hepatol; 2005 Oct; 43(4):569-73. PubMed ID: 16120470
    [No Abstract]   [Full Text] [Related]  

  • 10. Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?
    Grant D; Fisher RA; Abecassis M; McCaughan G; Wright L; Fan ST
    Liver Transpl; 2011 Oct; 17 Suppl 2():S133-8. PubMed ID: 21634006
    [No Abstract]   [Full Text] [Related]  

  • 11. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resection and liver transplantation for hepatocellular carcinoma.
    Llovet JM; Schwartz M; Mazzaferro V
    Semin Liver Dis; 2005; 25(2):181-200. PubMed ID: 15918147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effective evaluation of liver transplantation for hepatocellular carcinoma].
    Song SB; Zhang TL; Xiu DR; Yuan J; Wang DC; Jiang B; Wang CM
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1533-5. PubMed ID: 15500714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
    Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
    Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
    Kaido T; Takada Y; Uemoto S
    Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
    Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
    Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living donor liver transplantation for recurrent hepatocellular carcinoma.
    Liu C; Frilling A; Sotiropoulos GC; Weber F; Nadalin S; Malago M; Broelsch CE
    Transpl Int; 2005 Jul; 18(7):889. PubMed ID: 15948872
    [No Abstract]   [Full Text] [Related]  

  • 18. [Surgical treatment for hepatocellular carcinoma].
    Chen XP
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):411-2. PubMed ID: 19645135
    [No Abstract]   [Full Text] [Related]  

  • 19. Salvage live donor liver transplantation for a second recurrence of hepatocellular carcinoma.
    Sotiropoulos GC; Treckmann JW; Molmenti EP; Schmitz KJ; Cicinnati VR; Paul A; Broelsch CE; Malagó M
    Transpl Int; 2008 Feb; 21(2):182-5. PubMed ID: 17971034
    [No Abstract]   [Full Text] [Related]  

  • 20. Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries?
    Audet M; Panaro F; Piardi T; Wolf P
    Liver Transpl; 2009 Jul; 15(7):822-3; author reply 824-6. PubMed ID: 19562722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.